Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis
Authors:
- 8 December 2005
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 64 (1) , 68-73
Abstract
Summary: Background Ghrelin is a recently discovered protein hormone mainly synthesized in the gastric endocrine cells. This hormone not only is a potent growth hormone secretagogue but also is involved in the regulation of food ingestion and energy metabolism. Derangements in ghrelin secretion in patients with chronic renal failure (CRF) have not been fully evaluated.Objective Our aim has been to quantify serum concentrations of total ghrelin in a group of patients with CRF on chronic therapy with both haemodialysis (HD) and peritoneal dialysis (PD) in comparison with a group of patients on conservative management (predialysis).Patients and measurements We studied 68 CRF patients treated by HD (n = 30, 16 men, age 61·2 ± 1·8 years) and PD groups (n = 38, 21 men, age 54·4 ± 1·7 years). A group of 19 uraemic patients on conservative management served as the control. Serum concentrations of ghrelin, leptin, insulin, IGF I and GH were measured in all subjects.Results Patients undergoing HD showed similar concentrations of ghrelin in comparison with the control group (9491 ± 787 vs 9280 ± 918 pg/ml, NS). However, PD patients exhibited baseline ghrelin concentrations significantly lower than those found in patients on conservative management (3230 ± 216 pg/ml, P < 0·0001). Men and women showed similar serum ghrelin levels in both HD (9845·9 ± 1071 vs 9085 ± 1194 pg/ml) and PD patients (3214 ± 297 vs 3250 ± 324 pg/ml). Hypertension and diabetes mellitus did not influence ghrelin levels. Serum GH levels were positively correlated with serum ghrelin concentrations in both HD (r = 0·46, P < 0·05) and PD (r = 0·53, P < 0·001) patients; however, no relationships between ghrelin, leptin, insulin and IGF I were found.Conclusions These results suggest that PD is accompanied by a striking decrement in baseline ghrelin concentrations in comparison with values found both in HD and control patients. Further studies are necessary to determine mechanisms involved in ghrelin regulation in uraemic patients.Keywords
This publication has 27 references indexed in Scilit:
- Effects of small intestinal and gastric glucose administration on the suppression of plasma ghrelin concentrations in healthy older men and womenClinical Endocrinology, 2005
- Roles for ghrelin in the regulation of appetite and body weightCurrent Opinion in Endocrinology, Diabetes and Obesity, 2005
- Ghrelin: more than a natural GH secretagogue and/or an orexigenic factorClinical Endocrinology, 2004
- Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysisNephrology Dialysis Transplantation, 2004
- Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal studyNephrology Dialysis Transplantation, 2004
- Ghrelin and Des-Octanoyl Ghrelin Promote Adipogenesis Directly in Vivo by a Mechanism Independent of the Type 1a Growth Hormone Secretagogue ReceptorEndocrinology, 2004
- Identification, Characterization, and Biological Activity of Specific Receptors for Natural (Ghrelin) and Synthetic Growth Hormone Secretagogues and Analogs in Human Breast Carcinomas and Cell LinesThe Journal of Clinical Endocrinology & Metabolism, 2001
- Endocrine Activities of Ghrelin, a Natural Growth Hormone Secretagogue (GHS), in Humans: Comparison and Interactions with Hexarelin, a Nonnatural Peptidyl GHS, and GH-Releasing HormoneThe Journal of Clinical Endocrinology & Metabolism, 2001
- Ghrelin, a Novel Growth Hormone-Releasing Acylated Peptide, Is Synthesized in a Distinct Endocrine Cell Type in the Gastrointestinal Tracts of Rats and Humans1Endocrinology, 2000
- The Urea Reduction Ratio and Serum Albumin Concentration as Predictors of Mortality in Patients Undergoing HemodialysisNew England Journal of Medicine, 1993